| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/28/2002 | CN1089583C Mycophenolate mofetil high dose oral suspensions |
| 08/27/2002 | US6441183 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441032 Treating systemic lupis and multiple sclerosis |
| 08/27/2002 | US6441021 Type-iv collagenase inhibitors |
| 08/27/2002 | US6441014 Antiinflammatory agent, useful for treating cylcoocygenase-2 associated disorders |
| 08/27/2002 | US6441012 Chemical compounds |
| 08/27/2002 | US6441011 Combined preparation consisting of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 08/27/2002 | US6441004 Monocyte chemoattractant protein-1 inhibitor compounds |
| 08/27/2002 | US6440991 Ethers of 7-desmethlrapamycin |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440979 Aryl isoguanines |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440948 Thiophene A2A receptor agonists |
| 08/27/2002 | US6440938 Prevention and/or treatment of allergic conditions |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440679 Dermatomyositis-specific auto-antigen |
| 08/27/2002 | US6440468 Method for obtaining apolar and polar extracts of curcuma and applications thereof |
| 08/27/2002 | US6440419 J chain or portion thereof linked to at least one enzyme inhibitor; specifically binds to basolateral factor; eradi-cation of metastatic or nonpolarized cells; lung, breast, colon, ovarian and prostate carcinoma and endometriosis |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | CA2173939C Oligopeptides derived from c-reactive protein fragments |
| 08/27/2002 | CA2101548C Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/27/2002 | CA2015838C Method of topically treating acne vulgaris |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064598A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064595A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | WO2002064594A2 6-substituted pyrido-pyrimidines |
| 08/22/2002 | WO2002064592A1 Tricyclic crf receptor antagonists |
| 08/22/2002 | WO2002064591A2 Carboline derivatives |
| 08/22/2002 | WO2002064590A2 Carboline derivatives |
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064572A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | WO2002064571A1 Pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064568A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 08/22/2002 | WO2002064549A1 Ppar agonists |
| 08/22/2002 | WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064169A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases |
| 08/22/2002 | WO2002064165A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064164A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | WO2002064126A2 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | WO2002064109A2 Mucoadhesive pharmaceutical formulations |
| 08/22/2002 | WO2002064094A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002064080A2 Matrix metalloproteinase inhibitors |
| 08/22/2002 | WO2002064026A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | WO2002042280A3 Pyrimidine derivatives |
| 08/22/2002 | WO2002036587A3 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides |
| 08/22/2002 | WO2002032404A3 Nanoparticles |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2002002755A3 Regulation of human thimet oligopeptidase-like enzyme |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2000024907A9 Library of novel "unnatural" natural products |
| 08/22/2002 | WO2000023092A9 Contulakin-g, analogs thereof and uses therefor |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115716 Oral low dose butyrate compositions |
| 08/22/2002 | US20020115705 Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 08/22/2002 | US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates |
| 08/22/2002 | US20020115693 Treating a variety of central and peripheral disorders; useful as positive controls in assays for BK-2 receptor activity and when appropriately labeled as probes for the localization of BK-2 receptors in tissue sections. |
| 08/22/2002 | US20020115684 2, 7-naphthyridine derivatives |
| 08/22/2002 | US20020115662 Delta-opioid or mu-opioid receptor modulators; useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of respiratory diseases. |
| 08/22/2002 | US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
| 08/22/2002 | US20020115622 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020114837 Galenic composition for low bioavailability medicaments |
| 08/22/2002 | US20020114807 Administering drug comprising a substance that specifically recognizes extracellular domain of signal regulatory proteins and that inhibits functioning of pathologic myeloid cells |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438712A1 Method of treating of demyelinating diseases or conditions |
| 08/22/2002 | CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 |
| 08/22/2002 | CA2438551A1 Ppar agonists |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2437588A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |